Get a free consultation now:

(800) 407-9146

Celexa Birth Defects

Download Video: MP4, WebM, Ogg

Evidence has been linking Celexa (citalopram) and other antidepressants in the class known as selective serotonin reuptake inhibitors (SSRIs) to an increase in the risk of birth defects in babies whose mothers took the drugs during their pregnancies since 2005.

In 2006, the U.S. Food and Drug Administration (FDA) warned health care providers and consumers about a risk of the serious and life threatening birth injury to the lungs, persistent pulmonary hypertension of the newborn (PPHN) in babies who were exposed to an SSRI during the third trimester of development.

According to the FDA alert that was issued that year, babies have a greater risk of developing birth injuries like PPHN by 6 times then their mothers take certain antidepressants such as Celexa in the last three months of pregnancy.  Other birth defects that are believed to be linked to SSRIs include heart defects, abdominal walls defects, limb malformations, head and skull defects and more.

While some congenital defects are minor and have few or no symptoms, some birth defects, such as those that affect the heart and lungs, can have serious complications that last a lifetime. If your baby is born with any type of congenital abnormality, our Celexa birth defect lawyers would like to help you.

We recognize the devastation birth defects can cause and are dedicated to helping affected infants and families seek compensation for their suffering. To find out how we can help you, please contact us to schedule a free review of your case.

Top News

Rat Study Suggests Citalopram May Be Linked to Autism

A new study published in the Proceedings of the National Academy of Sciences suggests that taking selective serotonin reuptake inhibitors (SSRIs)... read more

Celexa, SSRIs Increase Risk of PPHN by 6 Times

Studies have shown that taking Celexa® after the 20th week of pregnancy could increase the risk of persistent pulmonary hypertension of... read more